76.30
price down icon0.16%   -0.05
 
loading
Precedente Chiudi:
$76.25
Aprire:
$76.75
Volume 24 ore:
79,984
Relative Volume:
0.03
Capitalizzazione di mercato:
$11.64B
Reddito:
$4.39B
Utile/perdita netta:
$-1.58B
Rapporto P/E:
-7.6606
EPS:
-9.96
Flusso di cassa netto:
$546.00M
1 W Prestazione:
+6.92%
1M Prestazione:
-13.51%
6M Prestazione:
-46.16%
1 anno Prestazione:
-38.04%
Intervallo 1D:
Value
$75.53
$76.94
Intervallo di 1 settimana:
Value
$69.83
$79.37
Portata 52W:
Value
$68.70
$156.66

Illumina Inc Stock (ILMN) Company Profile

Name
Nome
Illumina Inc
Name
Telefono
(858) 202-4500
Name
Indirizzo
5200 ILLUMINA WAY, SAN DIEGO, CA
Name
Dipendente
8,970
Name
Cinguettio
@illumina
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
ILMN's Discussions on Twitter

Confronta ILMN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Diagnostics & Research icon
ILMN
Illumina Inc
75.98 11.64B 4.39B -1.58B 546.00M -9.96
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
421.62 164.88B 42.88B 6.34B 7.27B 16.53
Diagnostics & Research icon
DHR
Danaher Corp
194.06 136.41B 23.88B 3.90B 5.30B 5.28
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
428.00 32.61B 3.90B 887.87M 798.08M 10.67
Diagnostics & Research icon
A
Agilent Technologies Inc
104.50 29.28B 6.53B 1.26B 1.31B 4.35
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
146.96 26.17B 15.41B 1.37B 2.11B 7.50

Illumina Inc Stock (ILMN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-03-04 Reiterato Citigroup Neutral
2025-02-28 Downgrade HSBC Securities Buy → Hold
2025-02-10 Downgrade Barclays Equal Weight → Underweight
2025-02-07 Downgrade TD Cowen Buy → Hold
2024-12-11 Downgrade Citigroup Buy → Neutral
2024-11-12 Ripresa Morgan Stanley Equal-Weight
2024-10-17 Aggiornamento HSBC Securities Hold → Buy
2024-08-28 Aggiornamento Argus Hold → Buy
2024-08-16 Aggiornamento Daiwa Securities Neutral → Buy
2024-08-14 Aggiornamento Barclays Underweight → Equal Weight
2024-08-14 Aggiornamento TD Cowen Hold → Buy
2024-07-10 Aggiornamento Citigroup Neutral → Buy
2024-06-03 Ripresa Jefferies Hold
2024-01-16 Downgrade HSBC Securities Buy → Hold
2024-01-04 Downgrade TD Cowen Outperform → Market Perform
2023-12-18 Aggiornamento Scotiabank Sector Perform → Sector Outperform
2023-12-15 Aggiornamento Bernstein Underperform → Mkt Perform
2023-12-14 Iniziato Guggenheim Buy
2023-12-14 Iniziato Stephens Overweight
2023-12-13 Iniziato Wolfe Research Outperform
2023-12-12 Downgrade BofA Securities Neutral → Underperform
2023-12-11 Aggiornamento Citigroup Sell → Neutral
2023-11-10 Downgrade Canaccord Genuity Buy → Hold
2023-09-28 Iniziato Bernstein Underperform
2023-07-05 Ripresa JP Morgan Neutral
2023-01-25 Downgrade Argus Buy → Hold
2023-01-05 Iniziato Scotiabank Sector Perform
2022-12-12 Downgrade Citigroup Neutral → Sell
2022-12-07 Iniziato RBC Capital Mkts Outperform
2022-10-04 Aggiornamento SVB Leerink Mkt Perform → Outperform
2022-09-28 Aggiornamento Evercore ISI In-line → Outperform
2022-08-25 Iniziato Credit Suisse Neutral
2022-07-13 Downgrade Barclays Equal Weight → Underweight
2022-01-18 Aggiornamento Stifel Hold → Buy
2022-01-11 Aggiornamento Barclays Underweight → Equal Weight
2022-01-07 Aggiornamento BofA Securities Underperform → Neutral
2022-01-06 Ripresa Morgan Stanley Equal-Weight
2022-01-06 Ripresa Piper Sandler Overweight
2021-10-15 Ripresa Cowen Outperform
2021-08-19 Downgrade SVB Leerink Outperform → Mkt Perform
2021-06-01 Aggiornamento Evercore ISI Underperform → In-line
2021-03-31 Downgrade Atlantic Equities Overweight → Neutral
2021-03-31 Aggiornamento Canaccord Genuity Hold → Buy
2021-03-03 Iniziato Barclays Underweight
2020-12-22 Aggiornamento Piper Sandler Neutral → Overweight
2020-12-17 Aggiornamento BTIG Research Neutral → Buy
2020-10-13 Downgrade Guggenheim Buy → Neutral
2020-09-30 Iniziato Atlantic Equities Overweight
2020-09-29 Downgrade Wolfe Research Outperform → Peer Perform
2020-09-22 Downgrade Stifel Buy → Hold
2020-09-22 Downgrade UBS Buy → Neutral
2020-09-21 Aggiornamento Guggenheim Neutral → Buy
2020-09-21 Downgrade JP Morgan Overweight → Neutral
2020-09-09 Iniziato Morgan Stanley Equal-Weight
2020-08-07 Downgrade Evercore ISI In-line → Underperform
2020-08-07 Downgrade Piper Sandler Overweight → Neutral
2020-07-07 Downgrade Guggenheim Buy → Neutral
2020-04-24 Downgrade Citigroup Buy → Neutral
2020-04-21 Downgrade Robert W. Baird Outperform → Neutral
2020-01-08 Iniziato Wells Fargo Underweight
2020-01-07 Iniziato Citigroup Buy
2020-01-02 Downgrade Evercore ISI Outperform → In-line
2019-11-15 Iniziato Stifel Buy
2019-10-25 Iniziato Guggenheim Buy
Mostra tutto

Illumina Inc Borsa (ILMN) Ultime notizie

pulisher
07:57 AM

Should You Hold Illumina (ILMN)? - Yahoo Finance

07:57 AM
pulisher
Apr 23, 2025

Veraxa makes a SPAC deal; Illumina discloses layoffs - Endpoints News

Apr 23, 2025
pulisher
Apr 22, 2025

Resmed Taps Illumina Exec for Chief Investor Relations Officer Role - Medical Product Outsourcing

Apr 22, 2025
pulisher
Apr 22, 2025

Microarray Market Projected To Witness Massive Growth, 2025-2032 | Thermo Fisher Scientific Inc.,Illumina Inc. - openPR.com

Apr 22, 2025
pulisher
Apr 22, 2025

DNA Microarray Technology Market: Innovations & Opportunities - openPR.com

Apr 22, 2025
pulisher
Apr 22, 2025

Cancer Biopsy Market Detailed In New Research Report 2025 | - openPR.com

Apr 22, 2025
pulisher
Apr 22, 2025

Genomic Cancer Testing Market Overall Study Report 2025-2032 | - openPR.com

Apr 22, 2025
pulisher
Apr 21, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 21, 2025
pulisher
Apr 21, 2025

Thomas Kean Jr purchases shares in Illumina and nVent Electric - Investing.com Australia

Apr 21, 2025
pulisher
Apr 21, 2025

Resmed Names Salli Schwartz as Chief Investor Relations Officer - The Manila Times

Apr 21, 2025
pulisher
Apr 21, 2025

Resmed Names Salli Schwartz as Chief Investor Relations Officer - GlobeNewswire Inc.

Apr 21, 2025
pulisher
Apr 21, 2025

Illumina, Inc. (ILMN): Among Recent Activist Investor Campaigns - Insider Monkey

Apr 21, 2025
pulisher
Apr 21, 2025

Controlling Genes Market Detailed in New Research Report By 2032 - openPR.com

Apr 21, 2025
pulisher
Apr 18, 2025

Illumina (ILMN) Receives a Buy from Leerink Partners - The Globe and Mail

Apr 18, 2025
pulisher
Apr 18, 2025

Illumina, Tempus AI partner to drive genomic testing beyond cancer - MedTech Dive

Apr 18, 2025
pulisher
Apr 18, 2025

Q4 Rundown: Illumina (NASDAQ:ILMN) Vs Other Life Sciences Tools & Services Stocks - Yahoo Finance

Apr 18, 2025
pulisher
Apr 17, 2025

DNA Methylation Market Deep Research Report with Forecast by 2032 | Illumina, Inc.,Thermo Fisher Scientific - openPR.com

Apr 17, 2025
pulisher
Apr 17, 2025

RNA Sequencing Market Size, Share, Outlook, Industry Analysis, - openPR.com

Apr 17, 2025
pulisher
Apr 17, 2025

MicroRNA Market Size, Share, Trends, Opportunities, - openPR.com

Apr 17, 2025
pulisher
Apr 16, 2025

AI in Omics Studies Market Overall Study Report 2025-2032 | Thermo Fisher Scientific, Agilent Technologies, Illumina - openPR.com

Apr 16, 2025
pulisher
Apr 15, 2025

Illumina, Tempus AI To Collaborate To Accelerate Genomic AI Innovation - Nasdaq

Apr 15, 2025
pulisher
Apr 15, 2025

Illumina and Tempus join forces to expand genomic testing By Investing.com - Investing.com India

Apr 15, 2025
pulisher
Apr 15, 2025

Illumina, Tempus AI Collaborating to Accelerate Clinical Use of Sequencing Tests - marketscreener.com

Apr 15, 2025
pulisher
Apr 15, 2025

Illumina And Tempus Partner To Drive The Future Of Precision Medicine Through Genomic Ai Innovation - MarketScreener

Apr 15, 2025
pulisher
Apr 15, 2025

Illumina and Tempus join forces to expand genomic testing - Investing.com

Apr 15, 2025
pulisher
Apr 15, 2025

Illumina and Tempus partner to drive the future of precision medicine through genomic AI innovation - PR Newswire

Apr 15, 2025
pulisher
Apr 14, 2025

BofA Securities Cuts Price Target on Illumina to $75 From $90, Keeps Underperform Rating - MarketScreener

Apr 14, 2025
pulisher
Apr 13, 2025

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Shareholders of Illumina, Inc.(ILMN) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire

Apr 13, 2025
pulisher
Apr 13, 2025

Illumina (NASDAQ:ILMN) Price Target Cut to $112.00 by Analysts at Royal Bank of Canada - MarketBeat

Apr 13, 2025
pulisher
Apr 12, 2025

Illumina : Welcomes Alex Aravanis as Chief Technology Officer and Appoints Mostafa Ronaghi to Lead Entrepreneurial Development - MarketScreener

Apr 12, 2025
pulisher
Apr 11, 2025

Personalized Medicine Market Forecast Report and Company Analysis 2025-2033 Featuring Abbott, GE, Aadi Bioscience, Illumina, QIAGEN, Eli Lilly and Co, Takeda, AbbVie, F. Hoffmann-La RocheResearchAndMarkets.com | FinancialContent - FinancialContent

Apr 11, 2025
pulisher
Apr 10, 2025

Illumina To Announce First Quarter 2025 Financial Results On Thursday, May 8, 2025 - MarketScreener

Apr 10, 2025
pulisher
Apr 10, 2025

Shareholders in Illumina (NASDAQ:ILMN) have lost 77%, as stock drops 6.8% this past week - simplywall.st

Apr 10, 2025
pulisher
Apr 10, 2025

Illumina to Announce First Quarter 2025 Financial Results on Thursday, May 8, 2025 - Yahoo Finance

Apr 10, 2025
pulisher
Apr 10, 2025

Single-cell Omics Emerging Technologies and Markets Report 2025: 10x Genomics, Thermo Fisher & Illumina Lead $9.1 Billion Single-cell Omics Market by 2029 - Yahoo Finance

Apr 10, 2025
pulisher
Apr 10, 2025

Cancer Profiling Market Positioned for Accelerated Growth with - openPR.com

Apr 10, 2025
pulisher
Apr 10, 2025

Illumina (ILMN) Receives a Sell from Barclays - The Globe and Mail

Apr 10, 2025
pulisher
Apr 09, 2025

Corvex’s Meister joins the board at Illumina. Here’s how he can create value for shareholders - MSN

Apr 09, 2025
pulisher
Apr 09, 2025

Genotyping Assay Market Surges to USD 37.1 Billion by 2029: - openPR.com

Apr 09, 2025
pulisher
Apr 09, 2025

Biotechnology company Illumina names Julie Hiner as comms head - Medical Marketing and Media

Apr 09, 2025
pulisher
Apr 09, 2025

PacBio to cut jobs, lower spending over NIH funding cuts and tariffs - MarketScreener

Apr 09, 2025
pulisher
Apr 09, 2025

DNA Data Storage Market to See Booming Growth 2025-2032 | Illumina, Inc.,Microsoft,Iridia, Inc.,Twist Bioscience - openPR.com

Apr 09, 2025
pulisher
Apr 08, 2025

DNA Sequencing Technologies Market Deep Research Report with - openPR.com

Apr 08, 2025
pulisher
Apr 08, 2025

Admera Health uses the NovaSeq X Plus to expand capabilities - Illumina

Apr 08, 2025
pulisher
Apr 08, 2025

RBC Cuts Price Target on Illumina to $112 From $128, Keeps Outperform Rating - MarketScreener

Apr 08, 2025
pulisher
Apr 08, 2025

Minimal Residual Disease Testing Market Forecast Report, 2025-2030 - GlobeNewswire Inc.

Apr 08, 2025
pulisher
Apr 08, 2025

Where are the Opportunities in (ILMN) - news.stocktradersdaily.com

Apr 08, 2025
pulisher
Apr 07, 2025

Deep Dive Into Illumina Stock: Analyst Perspectives (14 Ratings) - Benzinga

Apr 07, 2025
pulisher
Apr 07, 2025

Apple To $250? Here Are 10 Top Analyst Forecasts For Monday - Benzinga

Apr 07, 2025
pulisher
Apr 07, 2025

How Do Investors Really Feel About Illumina? - Benzinga

Apr 07, 2025
pulisher
Apr 07, 2025

California Public Employees Retirement System Reduces Position in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat

Apr 07, 2025

Illumina Inc Azioni (ILMN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
diagnostics_research DGX
$173.97
price down icon 0.05%
diagnostics_research LH
$222.92
price down icon 0.56%
diagnostics_research WAT
$328.78
price down icon 1.78%
$149.19
price up icon 3.02%
diagnostics_research MTD
$1,044.96
price up icon 4.17%
diagnostics_research IQV
$146.54
price up icon 2.44%
Capitalizzazione:     |  Volume (24 ore):